The Galleri test can detect a cancer signal shared by more than 50 types of cancer through a routine blood draw¹. View the list of cancers detected by a shared cancer signal at Galleri.com/50-cancers.
1. Klein EA, et al. Clinical validation of a targeted methylation-based multi-cancer earlydetection test using an independent validation set.Ann Oncol. 2021;32(9):1167-1177. doi:10.1016/j.annonc.2021.05.806.
2. Schrag D, Beer TM, McDonnell CH, et al. Blood-based tests for multi-cancer early detectionR): a prospective cohort study. Lancet. 2023;402:1251-1260. doi:10.1016/S0140- 36(23)01700-2.
GALLERI IS A REGISTERED TRADEMARK OF GRAIL, LLC.
"MCED testing fills a critical gap and ProvidenceGenomics helps clinicians understand andoffer this test to patients who may benefit.It has helped me discover cancers in mypatients, and exclude cancer as anexplanation for clinical symptoms."